Abnormal cardiac [123I]-meta-iodobenzylguanidine uptake in multiple system atrophy

Movement Disorders

Volumn 25, Issue 11, 2010, Pages 1744-1747

  Nagayama, Hiroshi ^a   Ueda, Masayuki ^a   Yamazaki, Mineo ^a   Nishiyama, Yasuhiro ^a   Hamamoto, Makoto ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

MIBG; Multiple system atrophy; Myocardial scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG UPTAKE; FOLLOW UP; HEART; HEART MUSCLE; HEART SCINTISCANNING; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDIASTINUM; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

3-IODOBENZYLGUANIDINE; AGED; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MYOCARDIAL PERFUSION IMAGING; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77955818963     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23338     Document Type: Article

References (15)

1. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004;3:93-103.
2. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2005;76:249-251.
3. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzyl guanidine myocardial scintigraphy. J Neurol Sci 1998;155:6-7.
4. Druschky A, Hilz MJ, Platsch G, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000; 175:3-12.
5. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98. (Pubitemid 29155424)
6. 123I-MIBG scintigraphy in patients with PSP, CBD and MSA. J Neurol 2006;253(suppl 3):III/35-III/40.
7. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 2001;11:351-355.
8. Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004;19:1391-1402.
9. Goldstein DS, Holmes C, Li S, Bruce S, Metman LV, Cannon III RO. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 2000;133:338-347.
10. Orimo S, Kanazawa T, Nakamura A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 2007;113:81-86.
11. Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. Alpha-synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol 2005;110:19-26.
12. Nishie M, Mori F, Fujiwara H, et al. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol 2004;107:292-298.
13. Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007;17:24-30.
14. Watanabe H, Ieda T, Katayama T, et al. Cardiac (123) I- metaiodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;70:781-783.
15. Nagayama H, Yamazaki M, Ueda M, et al. Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report. Mov Disord 2008;23: 1055-1057.